Health AI Central
Share:
Peer-Reviewed Publication
NPJ Digit Med2026;9(1)April 3, 2026Journal Article

Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review.

Julia Garcia1, Margaret M Mordin2, Bidur Banjara2, Cassondra Saande2, Katelyn R Keyloun3, Jessica L Abel4, Ari Gnanasakthy2, Bill Byrom5
1Health Economics and Outcomes Research Strategy, AbbVie, Irvine, CA, USA. Julia.k.garcia@abbvie.com.
2RTI Health Solutions, Durham, NC, USA.
3Digital and Data Strategy, AbbVie, Irvine, CA, USA.
4Patient Centered Outcomes Research, AbbVie, Florham Park, NJ, USA.
5eCOA Science, Signant Health, Nottingham, UK.
PubMed PMC DOI PDF

Abstract

Sensor-based digital health technologies (DHTs) enable continuous collection of physiological data, sensor-based functional outcomes, and performance outcomes in clinical and real-world settings. However, cross-therapeutic reviews examining sensor-based DHTs as outcome measurement tools rather than interventions in recent pharmaceutical and device trials are lacking, limiting understanding of prac…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.